SBIR-STTR Award

Multi-Core Biopsy Device with Volumetric Field of Tissue Acquisition (Moonshot)
Award last edited on: 6/3/2022

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$2,300,000
Award Phase
2
Solicitation Topic Code
383
Principal Investigator
Erez Nevo

Company Information

Robin Medical Inc

6607 Bonnie Ridge Drive Unit 101
Baltimore, MD 21209
   (410) 502-4152
   office@robinmedical.com
   www.robinmedical.com
Location: Single
Congr. District: 07
County: Baltimore City

Phase I

Contract Number: 75N91019C00009
Start Date: 9/16/2019    Completed: 8/31/2022
Phase I year
2019
Phase I Amount
$300,000
The problem: Tumor recurrence or resistance to treatment often arises due to tumor heterogeneityThere is a need to develop smart biopsy devicesto collect biopsies from multiple tumor coresto identify locations of the biopsiesto maintain physical characteristics of tumor on the extracted samplesto be used under current image guided practicesWe propose to further develop a prototype of multi core biopsy deviceMCBDthat we have already developed to enable collection of multi core tissue samples in a volume around the biopsy needleWe expect to provide prototype device that will enable rapid acquisition and preservation of multiple tissue cores under electromagnetic position navigationIf successfulthe project will have substantial commercial potential as the proposed device will facilitate the acquisition of multiple tissue cores in any tissue type and with any needle size and will improve the quality of biomolecular analysis by better preservation and handling of the tissue samplesThis research has substantial effect on public health as it can reduce healthcare cost by shortening image guided biopsy proceduresand it can improve patient management by better matching between tumor type and specific therapy based comprehensive evaluation of the tumor and better tissue preservation

Phase II

Contract Number: 75N91019C00009-P00002-9999-1
Start Date: 9/16/2019    Completed: 8/31/2022
Phase II year
2020
Phase II Amount
$2,000,000
The problem: Tumor recurrence or resistance to treatment often arises due to tumor heterogeneity. There is a need todevelop smart biopsy devices: 1) to collect biopsies from multiple tumor cores; 2) to identify locations of the biopsies; 3)to maintain physical characteristics of tumor on the extracted samples; 4) to be used under current image-guidedpractices. We propose to further develop a prototype of multi-core biopsy device (MCBD) that we have already developedto enable collection of multi-core tissue samples in a volume around the biopsy needle. We expect to provide prototypedevice that will enable rapid acquisition and preservation of multiple tissue cores under electromagnetic positionnavigation. If successful, the project will have substantial commercial potential as the proposed device will facilitate theacquisition of multiple tissue cores in any tissue type and with any needle size and will improve the quality ofbiomolecular analysis by better preservation and handling of the tissue samples. This research has substantial effect onpublic health as it can reduce healthcare cost by shortening image guided biopsy procedures, and it can improve patientmanagement by better matching between tumor type and specific therapy based comprehensive evaluation of the tumorand better tissue preservation.

Public Health Relevance Statement:


Project Terms: